Navigation Links
DTRA/SCC-WMD Announces $1 Million Algorithm Challenge
Date:12/13/2012

Fort Belvoir, VA (PRWEB) December 13, 2012

Nuclear warheads are not the only weapons of mass destruction threatening the United States and her allies. Because nuclear weapons require sophisticated technologies and elements difficult to obtain, the nation’s adversaries may find chemical and biological weapons easier to procure.

The Defense Threat Reduction Agency/U.S. STRATCOM Center for Combating Weapons of Mass Destruction (DTRA/SCC-WMD) is working hard to protect American warfighters and our allies from threats posed by chemical and biological weapons by innovating new technologies to detect chem/bio threats.

DTRA/SCC-WMD’s most recent initiative is “The DTRA Algorithm Challenge” – an open competition with a $1 million prize for the individual or team that develops an algorithm which can most rapidly and accurately characterize a complex clinical sample based solely on raw DNA sequence data.

“The Algorithm Challenge will lead to an enhancement of DTRA’s capability to diagnose and treat biothreats to the U.S. Armed Forces by giving DoD the ability to process and analyze biological sequence data rapidly in a realistic, moderate-to-low resource setting,” said Dr. Christian Whitchurch, Devices Branch Manager for DTRA’s Diagnostics, Detection and Disease Surveillance Division. “DTRA believes an open innovation development strategy is most likely to quickly yield a set of disruptive solutions to the threats posed by known, emerging, or engineered pathogens.”

This particular algorithm challenge focuses on using DNA sequence data in identifying pathogens in complex mixtures from clinical samples. By using sequencing as a diagnostic tool for infectious disease, the DoD will eventually have the ability to diagnose a larger number of threats (known and unknown) than ever before.

The Challenge winner will be whichever individual- or team-developed algorithm that best meets the following criteria:

  • Assesses the data, however complete or limited
  • Provides the best possible characterization of the sample
  • Identifies and quantifies all components when possible
  • Speculates (with probability and justification) when positive ID is not possible
  • Makes recommendations for further analysis
  • Does not rely on an expert user
  • Requires little overhead
  • Is fast

“Diagnostics is a critical area of emphasis for DTRA in creating new capabilities and products in detecting chemical and biological threats whether natural or intentional,” said Dr. Alan Rudolph, DTRA’s Director of Chemical/Biological Technologies. “The Algorithm prize is a great example where we are looking for novel solutions from advanced mathematics to unlock complex human diagnostic data to better determine health status that could inform on early and effective treatment options to these threats.”

Prize details and sequencing datasets will be made available in January 2013. For more information about the DTRA Challenge, visit the challenge website at http://www.innocentive.com/dtra.

DTRA is a combat support agency of the U.S. Department of Defense, founded in 1998, headquartered at Fort Belvoir, Virginia. Its mission is to safeguard the United States and her Allies from Weapons of Mass Destruction (Chemical, Biological, Radiological, and Nuclear) and High-Yield Explosives by providing capabilities to reduce, eliminate and counter the threat, and mitigate its consequences. Visit us on the Web at http://www.dtra.mil.

No. DTRA 2012-004

Read the full story at http://www.prweb.com/releases/dtra/algorithm/prweb10233480.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galileo Analytics Announces Agreement to Provide Analytic Component of ASCOs CancerLinQ Prototype
2. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida
3. Accelr8 Announces NASDAQ Capital Market Listing
4. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
5. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
6. Career Confidential Announces Release of New E-book About Using Recruiters
7. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
8. Innosight Announces Leadership Transition
9. My Cleaning Products Announces its Christmas Special, Sells Rusterizer at 20% Less
10. GenScript Announces Collaboration with AMDeC: Seeks to Decrease Biological Research Costs at NYC Area Institutions
11. Sequenom Announces Leadership Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):